Skip to main
ACHC

Acadia Healthcare (ACHC) Stock Forecast & Price Target

Acadia Healthcare (ACHC) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 31%
Buy 23%
Hold 38%
Sell 8%
Strong Sell 0%

Bulls say

Acadia Healthcare Co Inc. demonstrates a strong outlook driven by robust demand in the behavioral health sector, which has resulted in impressive organic growth through bed expansions and new developments. The company is positioned well for mergers and acquisitions due to strong capitalization, and it anticipates operational improvements as organic earnings growth is forecasted to rise. Additionally, a significant increase in net PLGL liability signals the company's proactive management of future claims amidst an environment of increasing claim frequency and associated costs.

Bears say

Acadia Healthcare Co Inc has faced a significant downward revision in its EBITDA guidance for 2025 by approximately 13.4%, reflecting a reduction of $94 million, primarily due to underestimating higher-than-expected PLGL expenses. Additionally, projections for 2026 anticipate continued elevated PLGL expenses between $100-110 million, which remain substantially above historical norms and are likely to pressure margins over the long term. This persistent increase in expenses, coupled with projected volume softness, leads to concerns that FY26 EBITDA may fall around 5% below current estimates, indicating a potential contraction in the enterprise multiple to levels significantly below historical averages for acute care hospitals.

Acadia Healthcare (ACHC) has been analyzed by 13 analysts, with a consensus rating of Buy. 31% of analysts recommend a Strong Buy, 23% recommend Buy, 38% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Acadia Healthcare (ACHC) Forecast

Analysts have given Acadia Healthcare (ACHC) a Buy based on their latest research and market trends.

According to 13 analysts, Acadia Healthcare (ACHC) has a Buy consensus rating as of Apr 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $21.54, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $21.54, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Acadia Healthcare (ACHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.